Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea

Starting soon · Not applicable

Conditions studied: Rosacea, Rosacea, Erythematotelangiectatic, Flushing

In brief

A single arm, pilot study among individuals with rosacea and at least moderate flushing or rednesss will be enrolled in a 4-week trial of taVNS. The particicpants will be followed for an additional 4-weeks following the intervention period to evaluate the durability of the results

Key facts

Study ID
NCT07600424
Run by
Brigham and Women's Hospital
People needed
10
Starts
2026-06-01
Expected to finish
2028-02-28
Last updated by the study team
2026-05-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.